scholarly journals Factors that determine the adherence to treatment by patients with psoriasis - pilot study

2018 ◽  
Vol 09 (03) ◽  
Author(s):  
Grochowiec Marcelina ◽  
Lesiak Aleksandra ◽  
Narbutt Joanna ◽  
Bednarski Igor
Keyword(s):  
Pilot Study ◽  
Adherence To Treatment

Effect of education and telephone counseling on adherence to treatment and challenges experienced in anti-TNF-α treatment: a pilot study

2018 ◽  
Vol 54 (1) ◽  
pp. 108-119 ◽  
Author(s):  
Ayse Ozkaraman ◽  
Guler Balcı Alparslan ◽  
Burcu Babadağ ◽  
Timucin Kaşifoğlu ◽  
Canan Baydemir
Keyword(s):  
Pilot Study ◽  
Telephone Counseling ◽  
Adherence To Treatment ◽  
Tnf Α

scholarly journals EARLY DETECTION OF POOR ADHERENCE TO TREATMENT OF PEDIATRIC RHEUMATIC DISEASES: PEDIATRIC RHEUMATOLOGY ADHERENCE QUESTIONNAIRE - A PILOT STUDY

2019 ◽  
Vol 37 (2) ◽  
pp. 149-155
Author(s):  
Vanessa Bugni Miotto e Silva ◽  
Karine Yoshiye Kajiyama Okamoto ◽  
Luciana da Silva Ozaki ◽  
Claudio Arnaldo Len ◽  
Maria Teresa de Sande e Lemos Ramos Ascensão Terreri
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
Early Detection ◽  
Medical Treatment ◽  
Rheumatic Diseases ◽  
Pediatric Rheumatology ◽  
Poor Adherence ◽  
Adherence To Treatment ◽  
Validity And Reliability ◽  
Patients At Risk

ABSTRACT Objective: To develop a questionnaire that allows the early detection of patients at risk for poor adherence to medical and non-medical treatment in children and adolescents with chronic rheumatic diseases. Methods: The Pediatric Rheumatology Adherence Questionnaire (PRAQ) was applied in recently diagnosed patients within a period of one to four months after confirmation of the rheumatic disease. After six months, the patients’ adherence to the medical and non-medical treatment was assessed. An internal consistency analysis was conducted to eliminate redundant questions in the PRAQ. Results: A total of 33 patients were included in the pilot study. Six months after the PRAQ had been applied, poor global adherence was observed in seven (21.2%) patients and poor adherence to medical treatment in eight (24.2%) patients. No correlation was observed between the PRAQ scores and the percentages of adherence, as well as the stratification for each index, except for a tendency to a correlation between socioeconomic index and poor adherence to medical treatment (p=0.08). A new PRAQ questionnaire with 25 of the 46 original questions was generated as a result of the reliability analysis. Conclusions: The usefulness of this questionnaire in clinical practice should be still evaluated. Due to the importance of a tool for the early detection of rheumatic patients at risk of poor adherence to treatment, the new PRAQ questionnaire should be reviewed and applied in a larger study to better define its validity and reliability.

scholarly journals Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

2020 ◽  
Author(s):  
Alain H Litwin ◽  
Laura Shafner ◽  
Brianna Norton ◽  
Matthew Akiyama ◽  
Linda Agyemang ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pilot Study ◽  
People Who Inject Drugs ◽  
Virologic Response ◽  
Fixed Dose ◽  
Adherence To Treatment ◽  
High Adherence ◽  
Visual Confirmation

Abstract This study evaluated health outcomes among people who inject drugs infected with hepatitis C virus using an artificial intelligence platform. Mean (SD) cumulative adherence (visual confirmation of administration) was 91.3% (SD=10.5%). Most subjects (88.2%) achieved ≥ 80% adherence to treatment and 88.2% (15 of 17) achieved a sustained virologic response.

Sign in / Sign up

Export Citation Format

Share Document